QUZYTTIR Drug Patent Profile
✉ Email this page to a colleague
When do Quzyttir patents expire, and what generic alternatives are available?
Quzyttir is a drug marketed by JDP and is included in one NDA. There are five patents protecting this drug.
This drug has five patent family members in five countries.
The generic ingredient in QUZYTTIR is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quzyttir
A generic version of QUZYTTIR was approved as cetirizine hydrochloride by PADAGIS US on June 17th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUZYTTIR?
- What are the global sales for QUZYTTIR?
- What is Average Wholesale Price for QUZYTTIR?
Summary for QUZYTTIR
International Patents: | 5 |
US Patents: | 5 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 119 |
Clinical Trials: | 2 |
Patent Applications: | 2,727 |
Drug Prices: | Drug price information for QUZYTTIR |
What excipients (inactive ingredients) are in QUZYTTIR? | QUZYTTIR excipients list |
DailyMed Link: | QUZYTTIR at DailyMed |


Recent Clinical Trials for QUZYTTIR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
JDP Therapeutics, Inc. | Phase 2 |
TerSera Therapeutics | Phase 2 |
TerSera Therapeutics LLC | Phase 2 |
Pharmacology for QUZYTTIR
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for QUZYTTIR
QUZYTTIR is protected by five US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | 9,180,090 | ⤷ Try for Free | ⤷ Try for Free | ||||
Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | 8,263,581 | ⤷ Try for Free | ⤷ Try for Free | ||||
Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | 8,314,083 | ⤷ Try for Free | ⤷ Try for Free | ||||
Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | 8,513,259 | ⤷ Try for Free | ⤷ Try for Free | ||||
Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | 9,119,771 | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for QUZYTTIR
See the table below for patents covering QUZYTTIR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2616703 | ⤷ Try for Free | |
World Intellectual Property Organization (WIPO) | 2011003074 | ⤷ Try for Free | |
Australia | 2010266103 | Non-sedating antihistamine injection formulations and methods of use thereof | ⤷ Try for Free |
Canada | 2803987 | FORMULATIONS POUR INJECTION D'UN ANTIHISTAMINIQUE NON SEDATIF ET LEURS METHODES D'UTILISATION (NON-SEDATING ANTIHISTAMINE INJECTION FORMULATIONS AND METHODS OF USE THEREOF) | ⤷ Try for Free |
European Patent Office | 2477634 | FORMULATIONS POUR INJECTION D'UN ANTIHISTAMINIQUE NON SÉDATIF ET LEURS MÉTHODES D'UTILISATION (NON-SEDATING ANTIHISTAMINE INJECTION FORMULATIONS AND METHODS OF USE THEREOF) | ⤷ Try for Free |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for QUZYTTIR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0058146 | 2001C/045 | Belgium | ⤷ Try for Free | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
0663828 | C300085 | Netherlands | ⤷ Try for Free | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for QUZYTTIR (Cetirizine Hydrochloride Injection)
More… ↓